Protocol for the Combined Diagnostic and Therapeutic Use of Recombinant Human Thyroid-Stimulating Hormone

Clinical Nuclear Medicine

Volumn 28, Issue 1, 2003, Pages 14-17

  Serafini, Aldo N ^b   Clauss, Ralf P ^a   Levis Dusseau, Silvina ^b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Radioiodine; Recombinant Human Thyroid Stimulating Hormone; Thyroid Cancer

Indexed keywords

RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; DIAGNOSTIC AGENT; RECOMBINANT PROTEIN; THYROTROPIN;

AGED; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; HYPOTHYROIDISM; RADIOISOTOPE THERAPY; THYROID CANCER; THYROID PAPILLARY CARCINOMA; BLOOD; METASTASIS; PAPILLARY CARCINOMA; PATHOLOGY; PREOPERATIVE CARE; SCINTISCANNING; THYROID TUMOR;

AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IODINE RADIOISOTOPES; PREOPERATIVE CARE; RECOMBINANT PROTEINS; THYROID NEOPLASMS; THYROTROPIN;

EID: 0037208904     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200301000-00004     Document Type: Article

References (10)

1. Thyroid Carcinoma Task Force: AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 7:202, 2001.
2. Haugen B, Pacini F, Reiners C, et al: A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877, 1999.
3. Ladenson PW, Braverman LE, Mazzaferri EL, et al: Comparison of administration of recombinant human thyrotropin with withdrawel of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888, 1997.
4. Perros P: Recombinant human thyroid stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience. J Endocrinol Invest 22:30, 1999.
5. Mariani G, Ferdeghini M, Angeri C, et al: Clinical experience with recombinant human thyrotropin (rhTSH) in the management of patients with differentiated thyroid cancer. Cancer Biotherapy & Radiopharmaceuticals 15:211, 2000.
6. Burmeister LA, Gaumaz MO, Mariash CN, et al. Levo thyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer. J Clin Endorinol Metab 75:344, 1992.
7. Colleran KM, Burge MR: Isolated thyrotropin deficiency secondary to primary empty sella in a patient with differentiated thyroid carcinoma: an indication for recombinant thyrotropin. Thyroid 9:1249, 1999.
8. Robbins RJ, Tuttle RM, Sonenberg M, et al: Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin. Thyroid 11:865, 2001.
9. Emerson CH, Colzani R, Braverman LE: Epithelial cell thyroid cancer and thyroid stimulating hormone: when less is more [editorial]. J Clin Endocrinol Metab 82:9, 1997.
10. Vargas GE, Uy H, Bazan C, et al: Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain. J Clin Endocrinol Metab 84:3867, 1999.